Your browser doesn't support javascript.
loading
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.
Long, Jun; Chen, Xinjie; Shen, Yan; Lei, Yichen; Mu, Lili; Wang, Zhen; Xiang, Rufang; Gao, Wenhui; Wang, Lining; Wang, Ling; Jiang, Jieling; Zhang, Wenjun; Lu, Huina; Dong, Yan; Ding, Yi; Zhu, Honghu; Hong, Dengli; Sun, Yi Eve; Hu, Jiong; Liang, Aibin.
Afiliación
  • Long J; Department of Hematology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Ton
  • Chen X; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shen Y; State Key Laboratory of Medical Genomics, Research Center for Experimental Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Lei Y; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Mu L; Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education, Department of Pathophysiology, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang Z; Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Xiang R; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Gao W; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang L; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang L; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Jiang J; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang W; Department of Hematology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Lu H; Department of Hematology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Dong Y; Department of Hematology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Ding Y; Department of Hematology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Zhu H; Department of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Hong D; Key Laboratory of Cell Differentiation and Apoptosis of Ministry of Education, Department of Pathophysiology, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: dl
  • Sun YE; Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: yi.eve.sun@gmail.com.
  • Hu J; Department of Hematology, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: hj10709@rjh.com.cn.
  • Liang A; Department of Hematology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Electronic address: lab7182@tongji.edu.cn.
Cell Rep Med ; 4(11): 101286, 2023 11 21.
Article en En | MEDLINE | ID: mdl-37951217
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Proteína p53 Supresora de Tumor Límite: Animals / Humans Idioma: En Revista: Cell Rep Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Proteína p53 Supresora de Tumor Límite: Animals / Humans Idioma: En Revista: Cell Rep Med Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos